Recently Approved Documents
Quality Management System Model for Respiratory Services (HS4-A2); Quality Management System Model for Medical Imaging Services (HS5-A2); Quality Management System Model for Inpatient Medication Use (HS10-A2); Newborn Screening Follow-up (I/LA27-A); Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria (M45-A); Bacterial Strain Typing (MM11-P); Diagnostic Nucleic Acid Microarrays (MM12-A)

HS4-A2—Application of a Quality Management System Model for Respiratory Services; Approved Guideline—Second Edition
This guideline describes the respiratory services path of workflow and provides information for respiratory services operations that will assist the services in improving their processes and meeting government and accreditation requirements.
Purchase here.

HS5-A2—Application of a Quality Management System Model for Medical Imaging Services; Approved Guideline—Second Edition
This guideline describes the medical imaging services path of workflow and provides information for imaging services operations that will assist the services in improving their processes and meeting government and accreditation requirements.
Purchase here.

HS10-A2—Application of a Quality Management System Model for Inpatient Medication Use; Approved Guideline—Second Edition
This guideline describes the hospital inpatient medication system path of workflow, and provides information for medication system operations that will assist the hospital pharmacy in improving its medication-related processes and meeting government and accreditation requirements.
Purchase here.

I/LA27-A—Newborn Screening Follow-up; Approved Guideline
This document describes the basic principles, scope, and range of follow-up activities within the newborn screening system, a process by which infants are screened for congenital diseases, which must be detected early for the prevention of morbidity and mortality. Intended for maternity and newborn healthcare providers, the medical home provider, the confirmatory services, and subspecialty medical consultants, as well as the family.
Purchase here.

M45-A—Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria; Approved Guideline
This document provides guidance to clinical microbiology laboratories for standardized susceptibility testing of infrequently isolated or fastidious bacteria that are not presently included in CLSI documents M2, M7, or M11. The tabular information in this document presents the most current information for drug selection, interpretation, and quality control for the infrequently isolated or fastidious bacterial pathogens included in this guideline.
Purchase here.

MM11-P—Molecular Methods for Bacterial Strain Typing; Proposed Guideline
This guideline examines the biology behind molecular strain typing and the process of characterizing and validating typing systems. The prevalent methods are described with particular attention to pulsed field gel electrophoresis (PFGE) and multilocus sequence typing (MLST).
Purchase here.

MM12-A—Diagnostic Nucleic Acid Microarrays; Approved Guideline
This guideline provides recommendations for many aspects of the array process including: a method overview; nucleic acid extraction; the preparation, handling, and assessment of genetic material; quality control; analytic validation; and interpretation and reporting of results. A CLSI-IFCC joint project.
Purchase here.

You may automatically receive or select approved-level documents as a member benefit.  Find out more about joining CLSI:  view membership options and benefits.

  [ return to top ]